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Abstract
Background: Endomyocardial Fibrosis (EMF) –is a chronic inflammatory disease of the heart with related pathology to that
of late stage Chaga’s disease. Indeed, both diseases are thought to result from auto-immune responses against myocardial
tissue. As is the case that molecular mimicry between the acidic termini of Trypanosoma cruzi ribosomal P0, P1 and P2b (or
simply TcP0, TcP1, and TcP2b) proteins and myocardial tissue causes Chaga’s disease, excessive exposure to certain
infections, toxins including cassava ones, allergy and malnutrition has been suggested as the possible cause for EMF. Recent
studies have defined the proteomic characteristics of the T. cruzi ribosomal P protein-C-termini involved in mediating auto-
immunity against Beta1-adrenergic receptors of the heart in Chaga’s disease. This study aimed to investigate the similarity
of C-termini of TcP0/TcP2b to sequences and molecules of several plants, microbial, viral and chemical elements- most prior
thought to be possible causative agents for EMF.
Methods and Principal Findings: Comparative Sequence alignments and phylogeny using the BLAST-P tool at the Swiss
Institute of Biotechnology (SIB) revealed homologs of C-termini of TcP0 and TcP2b among related proteins from several
eukaryotes including the animals (Homo sapiens,C .elegans,D .melanogaster), plants (Arabidopsis thaliana, Zea mays, Glycina
Max, Oryza sativa, Rhizopus oryzae) and protozoa (P. falciparum,T .gondii, Leishmania spp).The chemical formulae of the two
T.cruzi ribosomal protein C-terminal peptides were found to be C61H83N13O26S1and C64H87N13O28S1 respectively by
Protparam. Both peptides are heavily negatively charged. Constitutively, both auto-antigens predominantly contain
Asparagine (D), Glycine (G) and Phenylamine (F), with a balanced Leucine (L) and Methionine (M) percent composition of
7.7%. The afore going composition, found to be non-homologous to all molecules of chemical species in the databases
searched, suggests the possible role of a metabolic pathway in the pathogenesis of EMF if aligned with our ‘‘molecular
mimicry’’ hypothesis.
Conclusions: Our findings provide a ‘‘window’’ to suggest that cross reactivity of antibodies against C-terminal sequences of
several animal, plant and protozoal ribosomal P proteins with heart tissue may mediate EMF in a similar manner as C-
termini of T. cruzi do for Chaga’s disease.
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Introduction
Endomyocardial fibrosis or simply EMF is a restric-
tive cardiomyopathy known to affect persons of defined
geographical locales and socioeconomic status [1,2].
First described at the Department of Pathology-Maker-
ere University, Uganda by the Pathologist J.N.P Davies
in 1948[3], the important features of this disease—namely,
geographical distribution, cardiac specificity and preference for the
socioeconomically poor, have evaded a complete scientific explana-
tion despite the intense scientific scrutiny to which the disease has
been subjected[4,5]. Although the pathological lesions in EMF have
been clearly found to comprise fibrosis and calcification, possibly
resulting from long standing inflammatory responses, no natural
insult is evidenced to cause such pathology [5,6]. Specifically, in as
much as several potential insults have been proposed as the primary
causeforEMF,includingInfection(Toxoplasmosis,Rheumaticfever,
Malaria, Myocarditis and Helminthes [7]), allergy (Autoimmunity
and Eosinophilia [8]), malnutrition (Protein or Magnesium deficien-
cy[5,7]) and toxic agents(Cassava, other plant toxins, Arsenic[9],
Cerium, Thorium, Serotonin, or Vitamin D[5]); no single one is
proven[5,10]. Existing evidence for an ethnic predisposition points to
a possible genetic idiosyncrasy [11,12]. Largely because of the above
lack of evidence for a particular causative insult, the disease remains
unpreventable [5]. Recent studies indicate that there might indeed be
a decline in the incidence of EMF paralleled to improvement in the
socioeconomic welfare of high risk populations [4]. Until now, the
only evidenced benefit for drug use in EMF-deterring progression of
the inflammatory pathology, has revolved around steroids [13], with
the list of trial drugs expanding to include, more lately, serotonin
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myoectomy of pathological lesions (plus reconstruction of the heart
architecture), has a role despite its infrequent use due to poor state of
heart surgery available in regions where EMF is similarly prevalent
[15]. Ideally, all EMF patients with stage III and IV heart failure
would benefit from a heart transplant [15]. The foregoing picture
underlines the need to devise novel, cheap and yet still effective
medical interventions against EMF.
In the past, the pathophysiology of EMF has been closely
related to that of several other cardiomyopathies, including the
hypereosinophilic syndrome (Loffler’s disease)[15], and Chaga’s
disease[16]. Specifically, all diseases are known to possess a
spectrum of pathology that encompasses hypereosinophilia,
fibrosis and or, in long standing cases, calcification [15,16].
Recent studies have established molecular mimicry as the
mechanisms for pathology in some of the above EMF related
(particularly Chaga’s) cardiomyopathies [16]. Specifically, auto
antibodies to the acidic C- termini of two Trypanosoma cruzi (or
simply T.cruzi) ribosomal proteins (TcP0 & TcP2b, respectively:
EDDDDDFGMGALF and EEEDDDMGFGLFD) have been
associated with the chronic cardiac pathology of Chaga’s disease in
humans [16]. Martin et al. [17] have recently described, using 3-
dimensional modeling and docking experiments, a more clear
interaction of the structural elements involved in the autoimmune
mechanism of anti-P auto-antibodies cross-reaction and stimula-
tion of the b1-adrenoreceptor, results that may lead eventually to
the development of treatments to abolish receptor mediated
symptoms in Chaga’s disease( see Figure 1 for illustration
[17]). Given the prior observed related pathology in both diseases,
we hypothesized, that molecular mimicry may explain the
pathology seen in both diseases too. By so doing, we also sub-
hypothesized that the molecular insult in Chaga’s disease may
bear similarity (used interchangeably with resemblance here to
imply analogy and not necessary homology) to the insult
responsible for EMF. This study was conducted to examine the
specific-hypothesis that resemblance (analogy) between the C-
termini of the two T. cruzi ribosomal proteins TcP0/TcP2b and
prior suspected causative insults for EMF explains the common-
ality of gross pathology. Initially designed to comprise an initial
exploratory In Silico phase exploiting comparative sequence
alignments [18,19] and subsequent In Situ hybridization proof of
concept phase, the herein presented non-specific results of the
exploratory phase made it difficult to conduct parallel confirma-
tory In Situ inquiry due to a wide spectrum of test candidates and
limited resources. Specifically, contrarily to prior data pointing to
an architectural conservation of ribosomal P protein- structure
across some life domains, no sequence similarity was found
between the acidic termini of T.cruzi ribosomal P proteins TcP0/
TcP2b and sequences of all searched plant, microbial and viral
databases by initial NCBI microbial BLAST-P at default. Repeat
BLAST at SIB, however, revealed that both C-termini of T. cruzi
ribosomal P protein TcP0 and TcP2b exhibit homology to acidic
termini of respective eukaryotic proteins. Further, the C-termini of
TcP0 and TcP2b are noted to possess characteristic amino acid
composition that confer unto them acidity and negative charge.
Overall, we provide evidence to suggest that cross reactivity of
antibodies against C-terminal sequences of several animal, plant
and protozoal ribosomal P proteins with heart tissue may mediate
EMF in a similar manner as C- termini of T. cruzi do for Chaga’s
disease. It is, never the less, still possible that the mechanisms of
molecular mimicry between the suspected EMF-insults and
myocardial tissue are mediated via different myocardial antigens
altogether- thereby, making the specified protein-portions in our
study not the likely cause of EMF.
Results
1.0 Similarity of C-termini of TcP0 and TcP2b to analyzed
pathogen, plant, viral proteins and the human proteome
1.10NCBI BLAST-P at Default and other settings. But for
the hits on the source organism’s ribosomal proteins
(corresponding to the queries: acidic termini of TcP0 and TcP2b
[20–24]), no similarity was found to proteins of all searched
organismal, plant and viral protein genome wide databases
(PGDB; for details see Table 1 and Supporting file S1),
findings that were considered ambiguous in light of prior studies
[20–24]; and SIB BLAST-P tool[18,19,25] generated results
discussed below. Specifically, noticeable was that, despite the
presence of completed Toxoplasma genomes among the microbes
and several other protozoa including the pathogens of malaria and
leishmaniasis (that have previously been suspected to be potential
causative insults for EMF [5]); and particularly ones whose whole
length ribosomal proteins P0, P1, and P2 have been
phylogenetically related to those of T.cruzi[26,28], no sequence
homology or analogy was found with C-termini of P0, P1, and P2
proteins of over 2, 000 searched pathogens, plants, and viruses
species. We found this to be an error of default (discussed further
below) prompting us to repeat the alignments using the BLAST-P
tool at the Swiss Institute of Biotechnology (SIB).
1.20 SIB BLAST-P at default setting. Repeat alignments of
acidic termini of TcP0 and TcP2b sequences with sequences of
proteins available in the Swiss Prot database using BLAST-P at
SIB, contrarily to findings of the NCBI BLAST-P tool above,
revealed homologs of both TcP0 and TcP2b acidic termini of
eukaryotic origin; including from animals ( Homo sapiens,C .
elegans,D .melanogaster), plants(Arabidopsis thaliana, Zea mays, Glycina
Max, Oryza sativa, Rhizopus oryzae) and protozoal (P. falciparum,T .
Figure 1. Showing the binding site of the acidic C-termini of
the T. cruzi ribosomal P proteins on the specific human
antibody. The Figure illustrates the unique binding feature conferred
by the positive charge within the binding site of the acidic C-termini of
the T. cruzi ribosomal P proteins (themselves negatively charged) on the
specific human antibody. The van der Waals surface is coloured
according to the electrostatic potential calculated with the program
Poisson-Boltzman electrostatics calculated employing using APBS as
implemented in PyMol with default charge settings and dielectric
constant 80 (Receptor coloured by calculated charge from red 21t o
blue +1). Note that the binding site of the peptides is a positive charged
cavity. This work is reminiscent of the recent findings towards a better
understanding of the molecular pathology of Chaga’s disease, citation
[17] Martin OA, Villegas ME, Aguilar CF (2009) Three-dimensional studies
of pathogenic peptides from the c-terminal of Trypanosoma cruzi
ribosomal P proteins and their interaction with a monoclonal antibody
structural model. PMC Biophys. 2(1):4.
doi:10.1371/journal.pone.0007420.g001
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for detailed results). The other species that possess
homologous C-termini of P ribosomal proteins to those of T
cruzi are listed here along with their ‘‘common names’’: Toxoptera
citricida aka citrus aphid, Acyrthosiphon pisum aka pea aphid, Argas
monolakensis aka mano lake bird tick, Diaphorina citri aka Asian
Citrus Phyllid, Ixodes scapularis aka Black-legged tick; Haemaphysalis
longicornis aka Bush tick, Artemia salina and Artemia franciscana aka
Brine shrimp, Blomia tropicalis aka Mite, Ceratitis capitata aka
Mediterranean fruit fly; Pichia pastorilis aka yeast, Saccharomyces
cerevisiae aka Baker’s yeast; Leishmania spp; Bombyx mori aka Silk
moth; Suberites domuncula aka Sponge, Asterina pectinifera a aka
Starfish; and Candida sphaerica. Figure 2 shows the schematics of
these BLAST hits obtained by querying TcP2B on the Swiss Prot
database, while Figure S1 shows a resultant taxonomic tree from
the same search.
2.0 Primary structure and chemical composition of the C-
terminus of TcP0 and TcP2b
The chemical formulae of the two T.cruzi ribosomal P proteins’
acid termini were found to be C61H83N13O26S1and
C64H87N13O28S1 respectively. Details of the amino acid compo-
sition, molecular weight, Theoretical PI, Atomic composition,
extinction coefficient, Aliphatic Index and hydrophobicity are
shown in Supporting files S3 and S4. Note that chemically,
both peptides may be classified as polycarbonated. Surprisingly,
although both C-terminal peptides were noted to contain closely
similar amino acid compositions, their respective predicted
Instability Indices (II) are differing, with the terminus of TcP0
being stable (at an II value of 11.7) and that of TcP2b unstable (II
value of 83.69). Generally, any peptide with an II above 40 is
denoted as unstable [25]. These findings-discussed further below,
serve to emphasize, how, proteins with closely related amino acid
composition may possess differing In Vivo biophysical profiles and
thus possibly functions as well.
2.0 Similarity of the C-terminus of TcP0 and TcP2b to
known chemical species
Constitutively, both auto-antigens( acidic termini of TcP0 and
TcP2b ) were found to predominantly contain Asparagine(D),
Glycine(G) and Phenylamine(F), with a balanced leucine(L) and
methionine(M) percent composition of 7.7%(see Supporting
files S3 and S4 for details); composition that was found to be
non-homologous to any known chemical species to date. Note that
this composition is associated with extensive negativity of the
peptides- overall charge, uniquely imposed by the amino acids
Asparagine and glutamine that are most present within the
constitution of both peptides. This is not surprising, since both
these terminal peptides are found localized within the acidic C-
termini of the T. cruzi ribosomal proteins [16,17]. Specifically,
these findings tally with the findings of Martin et al.[17]’s 3-
dimentional structure of TcP0/TcP2b acidic termini specific
human antibody model that exhibits a most remarkable feature in
the active site, the positively charged, narrow and deep cavity
where these acidic residues 3 to 6 are accommodated, further
emphasizing the fact that the most important elements in the
molecular peptide recognition by the antibody may be the shape of
the loop and the presence of negative charges in positions 3–5 of
the acidic peptides P0, P2b [17]. Although rather improbable(and
apparently non- evidenced); the notable absence of the positively
charged amino acid residues Argenine and Lysine in both the C-
terminal sequences of TcP0 and TcP2b prompted us to speculate,
whether or not, a deficient diet on Arginine and Lysine could lead
to EMF. Several pathways are possible here fore, including: either
eliciting a plethora of ‘‘systemic effects’’(because of their role as
precursor or intermediates on several metabolic networks) or
having a direct pathological impact on protein biosynthesis (as
direct precursor of proteins) [5,7].
Discussion
Our findings offer the first ever evidence to support the
postulate that cross reactivity of antibodies against C-terminal
sequences of ribosomal P proteins from several animals, plant and
protozoal with heart tissue may mediate EMF in a similar manner
as C- termini of T. cruzi do for Chaga’s disease. Overall, despite
previous studies implicating several factors in the etiology of
EMF[5], including the evidenced role of ethnicity [6] and
suspicions around Infections (Toxoplasmosis, Rheumatic fever,
Malaria, Myocarditis and Helminthes [7]), allergy (Autoimmunity
and Eosinophilia [8]), malnutrition (Protein or Magnesium
deficiency[5,7]) and toxic agents(Cassava, other plant toxins,
Arsenic[9], Cerium, Thorium, Serotonin, or Vitamin D[5]) as the
primary EMF insult; none is yet proven[5,10]. Collectively, the
pathology seen in EMF has been suspected to be mediated via
similar molecular mimicry mechanisms as is seen in Loffler’s and
Chaga’s disease [16]. In light of the recent advances towards
understanding the mechanism of molecular mimicry seen in
Chaga’s disease resulting from resemblance of the C-terminal
peptides of T.cruzi ribosomal P (TcP0 and TcP2b) proteins to
cardiac tissue (see Figure 1) [16,17], we felt it responsive to
investigate the potential resemblance (analogy) of the above
various suspected insults in EMF to the same (C-termini of T. cruzi
ribosomal proteins TcP0 and TcP2b). Both P0 and P2 are a major
component of the GTPase center of the large ribosomal subunit.
The GTPase center, which is located at the N-termini, and
functions as a landing platform for translation factors- is regarded
as one of the oldest structures in the ribosome and is, presumably,
one universally conserved structure in all domains of life [26–28].
It has been hypothesized that this structure could indeed be
responsible for the major breakthrough on the way to the RNA/
protein world, since its appearance would have dramatically
increased the rate and accuracy of protein synthesis. Notably, one
of the most characteristic ribosomal structures is the stalk: a highly
flexible and universal lateral protuberance on the large subunit
Table 1. Showing the hits in the T.cruzi Proteome as the native source of the TcP0 C-terminus queried.
Seq. ID Sequence Producing significant alignment Sore (Bits) E value
gb|EAN99267.1| 60S acidic ribosomal protein P0 [Trypanosoma c… 29.3 2.2
gb|EAN99266.1| 60S acidic ribosomal protein P0 [Trypanosoma c 29.3 2.2
Note that the low score values above do not indicate a lower similarity, but rather the fact that the query only made up a small portion of the entire 60S acidic ribosomal
protein P0 of T,cruzi. Overall, both hits are 100% homologous to the respective match segments of 60S acidic terminus of the T.cruzi ribosomal protein P0.
doi:10.1371/journal.pone.0007420.t001
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Species spp. Sub-type/Protein where known % Identity
Trypanosoma spp. 100
T.cruzi/P2B
T.cruzi/P2A;P-JL5/L12E
T.cruzi/P1
T.cruzi/P2
T.brucei/? P2
Drosophila spp. 100
D.Melanogaster/P0 or DNA-APE
D. pseudoobscura pseudoobscura/?
D.simulans
D. yakuba
D. willistoni
D. virilis
D. mojavensis
D. grimshawi
D. sechellia
D. erecta
D. ananassae/P0
Leishmania spp 92
L. infantum/P21-LIP
L. Donovani/P2
L. braziliensis/P2B
L. peruviana/P1
L. major/P2
Others spp .90; #100
Sarcophaga crassipalpis/P0 100
Toxoptera citricida/P0 100
Acyrthosiphon pisum/P0 100
Diaphorina citri/P0 100
Ixodes scapularis/P0 100
Haemaphysalis longicornis/P0 100
Kluyveromyces polysporus/? 100
Vanderwaltozyma polysporus/? 100
Artemia salina/P2 100
Blomia tropicalis/Blot alt-a6 allergen 100
Ceratitis capitata/P0 100
Babesia rodhaini/P0 92
Pichia pastoris/P2A 92
Melampsora medusae f. sp. Deltoidis/P1 92
Branchiostoma floridae-Amphioxus/P2 92
Saccharomyces cerevisiae/P0 92
Branchiostoma belcheri-Amphioxus/P1 92
Bombyx mori/P0 92
Suberites domuncula-Sponge/P2 92
Suberites domuncula-Spongeb/L10e/P0 92
Pectinaria gouldii -Trumpet worm/P1 92
Lepeophtheirus salmonis-louse/P2, P0 92
Note that some of the hits in Trypanasoma spp., Drosophila spp., and Leishmania spp., -although possessing the indicated identities, have score and E-values that places
them at a lower place(for details, see supporting File 2).
doi:10.1371/journal.pone.0007420.t002
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PLoS ONE | www.plosone.org 4 October 2009 | Volume 4 | Issue 10 | e7420Figure 2. Showing the schematics of the BLAST hits obtained by querying the C-termini of TcP2b across a Swiss Prot database using
the BLAST tool at SIB. The Figure illustrates the schematics of the Scores and E values of hits obtained by querying the 13 amino acid sequences of
the C-termini of TcP2b (EEEDDDMGFGLFD) across a Swiss Prot database using the BLAST tool at SIB. Note the presence of a key at the bottom to
annotate meaning to the colors. Interpretation of this schematics may be best done with table 2 and supplementing file 2 in hand. Briefly, % identity
of hits declines as the green color (signifying 100% identity) fades from green to finally red (signifying 0% identity).The data was generated by the
BLAST tool at the following URL: SIB availablehttp://www.expasy.ch/cgi-bin/blast.pl
doi:10.1371/journal.pone.0007420.g002
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participating in the translocation mechanism [28]. In eukaryotes
the stalk is formed by the pentameric complex P0–(P1)2 (P2)2 that
is reminiscent of the bacterial complex L10–(L7/L12)4.I n
particular, the P0 protein is the eukaryotic L10 equivalent and
has a key role in the stalk structure[z]. Interestingly, prior studies
have actually pointed to conservation of ribosomal proteins from
species within the related life Domain [26,27]. Functionally, these
proteins bind to the highly conserved 26S/28S rRNA GTPase
center through the N-terminal domain [28] at sites that are
equivalent to those found in bacteria [26,28]. The P0 C-terminal
domain, in particular, is known to interact with the acidic
phosphoproteins P1 and P2 (the L7/L12 equivalents) through
their N-terminal domains, forming the tip of the stalk [28]. The
main functional part of the stalk in all domains of life is composed
of small L12/P proteins- and these have, until now, been believed
to form an evolutionarily conserved group in all species. We show
in Tables 1 and 2 plus Supporting files S1 and S2, that
although no sequence similarity was found between the acidic
termini of T.cruzi ribosomal P proteins TcP0/TcP2b and
sequences of all searched plant, microbial and viral databases by
initial NCBI microbial BLAST-P at default settings, in line with
prior data pointing to an architectural conservation of ribosomal P
protein- structure across some life domains[26–28], repeat
alignments using the BLAST-P Software and algorithms at the
Swiss Institute of Biotechnology (SIB), revealed homologs of both
studied C-termini of TcP0 and TcP2b with ribosomal P proteins
(and in one incidence-D. melanogaster: DNA Apurinic apyramidinic
endonucleases-APE) of several eukaryotes including the animals
( Homo sapiens,C .elegans,D .melanogaster), plants(Arabidopsis thaliana,
Zea mays, Glycina Max, Oryza sativa, Rhizopus oryzae) and protozoa
(P. falciparum,T .gondii, Leishmania spp. The schematics of those
BLAST hits obtained by querying TcP2B on the Swiss Prot
database are shown in Figure 2, while Figure S1 shows the
taxonomic tree from the same). Grela and colleagues [28] recently
performed a comprehensive comparative analysis of the L12/P
proteins from the three domains of life and found that bacterial
and archaeo/eukaryal L12/P-proteins are not structurally related
and, therefore, might not be linked evolutionarily either.
Consequently, it has been suggested that proteins be regarded as
analogous rather than homologous systems and probably ap-
peared on the ribosomal particle in two independent events in the
course of evolution [28]. Therefore, in as much as prior insights
into the structure of the ribosomes and their components at high
resolution leaves no question that the overall architecture of the
translational machinery of the cell has been strongly conserved in
all kingdoms, it is worth noting that inter-kingdom differences
among ribosomal components may inevitably exist, even though
the functional significance of these structural variations has not
been clarified yet [26–28]. Overall, our findings of several
eukaryotic homologs of T.cruzi ribosomal P protein acidic termini
provide a ‘‘window’’ to suggest that cross reaction of antibodies
against C-terminal sequences of several animal, plant and
protozoal ribosomal P proteins with heart tissue possibly mediates
EMF in a similar manner as C- termini of T. cruzi do for Chaga’s
disease. It is, nevertheless, equally still likely that the mechanisms
of molecular mimicry between prior suspected EMF-insults and
myocardial tissue are mediated via different myocardial antigens-
thereby, making the specified protein-portions in our study not the
likely cause of EMF.
Considering that our ‘‘molecular mimicry’’ hypothesis is
affirmed in animal models for EMF as has been for Chaga’s[17],
one of the major challenges to explore in future will be
determining the likely mechanism of exposure to the these, now
observed as, eukaryota conserved ribosomal P protein C-termini.
We postulate that metabolic uptake may be such one candidate
route of exposure to consider. The possibility that metabolic
uptake of the still undefined insult plays a role in the aetiology of
EMF arises in light of earlier work that had speculated that
metabolites of plantain ingestion (specifically 5-hydroxyindolyla-
cetic) may be the cause of EMF [29,30]. In a latter controlled
study of thirty Nigerians with established endomyocardial fibrosis,
however, Ojo [31] found that no significant increase in serum 5-
hydroxytryptamine levels occurred in these patients after plantain
ingestion. This finding underlined the difference between
endomyocardial fibrosis and carcinoid heart disease by proving
that no correlation exists between the incidence of endomyocardial
fibrosis and the high content of 5-hydroxytryptamine in the local
dietary staples [31]. Note, however, that it did not rule out the
possibility that another nutritional metabolite other than 5-
hydroxytryptamine may be the primary insult, a fact that is
further underscored here by the characteristic amino acid
composition and negative charge orientation of both studied T.
cruzi ribosomal proteins- TcP0 and TcP2b C-termini in Sup-
porting files S3 and S4(notably, high content of Asparagine(D),
Glycine(G) and Phenylamine(F), with balanced leucine(L) and
methionine(M) percent composition of 7.7%; and large negative
(-6) charged. The latter, charge orientation and amino acid
content, have lately been determined to be the major determinants
for interaction between acidic termini of TcP0 and TcP2b and
specific auto- antibodies(see Figure.1 for illustration) [17].
Our search for alternate such possible related chemical species,
nevertheless, failed to yield any matching chemical species. There
is hence need to conduct metabolome wide association studies
(MWAS) to ascertain what metabolites are common among
persons with EMF or EMF preceded hypereosinophilia.
We note a number of specific short -comings of using the
BLAST-P method for this study. First, while it is clear that
protein and peptide composition are important for their biological
function, the same is not always straightforward in their primary
structure formats. Rather, the 3D structure and the dynamics of
peptides and proteins in solution are much more important, in
terms of biological function. Against this background,
perhaps this study would better have been conducted
using 3-D structural searches. All in all, it is widely
established that only those proteins with a sequence identity of
at least ,30% are highly probable to share an evolutionary
ancestor and to share the same overall fold (with the probability
increasing as the identity sequence increase)[26,28]. Second,i na s
much as the afore-going account is a useful rule of thumb for
proteins in general, it is likely that, for peptides, the panorama is
much more complex. For instance, as described by Martin et al.
[17], the C-terminal portion of P2B protein from Leishmania
brazilensis, Trypanosoma cruzi and Homo sapiens, respectively differ
in only one amino acid. However, while R13 and H13 are capable
of binding to a specific monoclonal antibody; A13 is not capable of
such action. On the other hand, the second extracellular loop of
rhodopsine is able to bind to the same antibody (less tightly) in
spite of the poor sequence similarity to R13 or H13. Lastly, even
with our positive findings, there is a slight possibility that no shared
mechanism of pathology in Davies and Chaga’s diseases actually
exists. In assuming the latter position (one that is likely for some as
our study coins no particular EMF causative insult), those of this
line of philosophy may need to note that it is equally agreeable at
the moment to further postulate that the fundamental mechanisms
of aetiology are similar (in that, they involve autoimmunity), but
EMF responsible auto-antigens are completely different from the
acidic termini of the T.cruzi ribosomal proteins TcP0 and TcP2b
The Molecular Cause of EMF
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sustain can only but be speculative; given that our search for
related chemical species in known databases by way of NIST and
SureChem yielded no currently known species with the primary
structures C61H83N13O26S1and C64H87N13O28S1 consistent with
the T.cruzi ribosomal acidic C-termini peptides. This also rules-out
the possibility that previous chemical toxins such as Cerium,
Thorium [5], and Arsenic [9] may mediate EMF through similar
antigens/charge as do the acidic termini of TcP0 and TcP2b, for
Chaga’s diseases.
Lastly, besides the above noted potential shortcomings of our
methodologies; two outstanding ambiguities in our study findings
warrant further discussion and explanation. First, that the NCBI
BLAST-P tool at default setting yielded results contradictory of
existing data on the phylogenetic relationship of ribosomal P
protein C-terminal repeats among eukaryotes [26–29] requires
explanation. Need for such an explanation was, objectively, made
further necessary in light of the fact that- in a recent study, we
successfully used related approaches to evidence the species
specific conservation of a sub-group of mosquito non- Long
Terminal Repeat (non-LTR) small coding RNAs of the Long
Interspersed Nuclear Elements (LINE) class- retroposons [32];
with insignificant differences observed from results obtained by
other tools including a protein clock and genome cross-referencing
or XREFdb [33–35]. However, in order to reduce errors in
alignment searches, the default setting of the NCBI BLAST-P tool
are designed not to permit database searches employing short-
repetitive sequence queries [18,19]. Therefore, unless the filter is
turned off, no result (hit) can be obtained-the case observed in our
report. Second, despite both peptides sharing related negative
charge orientation, closely similar structures and amino acids
content (see Figure 1), their respective predicted Instability
Indices (II) were differing, with TcP0 being stable (at an II value of
11.7) while TcP2b is unstable (II value of 83.69). Generally, any
peptide with an II above 40 is denoted as unstable [25]. This was
interpreted-likely prematurely; as indicative of the possibility that
variability in stability of both peptides per se does not influence
their biological half life, both of which are shown to be 1 hour
within mammalian reticulocytes (see Supplementary files 2 and 3).
Third and last, while previous studies of EMF clearly show the
possible role of genetic variants, geographical locales and
socioeconomic status in the etiology of EMF [5,6], our work is
limited in that, although studying the insults possibly common in
these groups, it never took consideration of those other factors
including age and genetic variations. Specifically, Freer et al.[6], in
an unmatched case control study in Mulago Hospital, Kampala of
61 EMF patients and 120 controls, show that EMF patients were
significantly more likely than controls to have Rwanda/Burundi
ethnic origins (P=0.008), be peasants (P,0.001), and to come
from defined geographical locations (P=0.003). Elsewhere,
Mocumbi et al. [11] not only highlighted the familial and endemic
nature of the disease in tropics but also identified early disease and
asymptomatology to occur among such subjects. Therefore,
amidst the emerging role of genomics in infectious and neglected
tropical diseases [36], it may equally be necessary to conduct
genome wide association studies (GWAS) to establish the
particular small nuclear polymorphisms (SNPs) among persons
from these established ethnic and geographical locales that make
them highly susceptible to EMF. The fusion protein FIP1L1-
PDGFRa, a constitutively activated tyrosine kinase found in as
many as half of those with the idiopathic hypereosinophilic
syndrome, has emerged as a therapeutic target for imatinib [5,37].
The recent finding that serotonin acts as a chemotactic factor for
eosinophils also underlines the need for inquiries into the role of
this pathway in EMF [38]. Zanettini and colleagues [39] have
found that some anti- Parkinson medications induce valvular
fibrosis via their action on 5HT2B receptors. GWAS studies are
called for to determine whether or not, polymorphisms in these
and other receptors influence susceptibility to EMF in the presence
of intermittent Eosinophilia, in which case, existing drugs may be
tried in EMF.
In conclusion, our findings provide a ‘‘window’’ to suggest that
cross reactivity of antibodies against ribosomal P protein C-termini
of several animal, plant and protozoal with heart tissue may
mediate EMF in a similar manner as C- termini of T. cruzi do for
Chaga’s disease. It is, however, equally possible that the
mechanisms of molecular mimicry between the suspected EMF-
insults and myocardial tissue are mediated via different myocardial
antigens- thereby, denoting these-our study alluded species-protein
portions, not the likely cause of EMF.
Materials and Methods
A. Comparative alignment of TcP0 and TcP2b acidic
terminal Sequences with over 1, 789 organismal
Proteomes
A1. NCBI BLAST-P. Sequence alignments were conducted by
querying sequences of the acidic termini of the two T.cruzi ribosomal P
proteins TcP0 and TcP2b [ the latters’ Swiss Prot Accessions
numbers areP26796 and Q26957, respectively]’s known to mediate
autoimmune responses in Chaga’s diseases: EDDDDDFGMGALF
and EEEDDDMGFGLFD across an over 1,789 organismal
proteome database, 20 plant (including cassava) proteome
database by way of BLAST-P Software and Algorithms[18,19] at
default setting[ and hence after, repeated with altered algorithms
E=1–10, A & D=10–100]. On the other hand, similarity to viral
genomes was determined by querying entire peptides’ cross
referenced DNA/mRNA sequences (derived from mRNA
sequences of mRNA of the TcP0 [20,21,22] -NCBI Accession
X65066; and the whole genomic short gun of T.cruzi[23,24]- NCBI
Accession NW_001849569) across a database of ssRNA, ssDNA,
dsRNA and dsDNA viral genomes employing NCBI’s viral
genotyping and dsDNA BLAST-N respectively[18,19]. The latter
approach( use of whole reference gene nucleotide sequences rather
than amino acids sequences] was employed because the currently
available BLAST algorithm and software linked to the viral
databases only support nucleotide (N) searches
A.2 SIB BLAST-P Tool. (available at URL: http://www.
expasy.ch/cgi-bin/blast.pl)
Repeat alignment of acidic termini of TcP0 and TcP2b with
sequences of proteins available in the Swiss Prot database using
BLAST-P at SIB were conducted as prior described by Altschul
et al., [18,19].
B. Computational Derivation of TcP0 and TcP2b acidic
terminal chemical composition
To be able to search across chemical species databases (see
method 3 below), we needed to derive the chemical formulae of the
acidic termini of both TcP0 and TcP2b. The Expasy software
Protparam[25]wasusedtoachievethis.Briefly,Protparam[25]isa
proprietary computational software available at Swiss Prot/UniProt
that can be used to derive series biophysical profiles as well as
determinetheaminoacidcompositionofanyproteinorpolypeptide
of interest,provided itsprimarystructure (linear alignmentof amino
acids) is known. The Software has a user interface that allows one to
feed the respective peptide or polypeptide primary structure into it,
hence fore computing the parameters.
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The chemical formulae of the acidic termini of TcP0 and
TcP2b obtained above: C61H83N13O26S1and C64H87N13O28S1
respectively, were used to search for relationship to chemical
toxins like Cerium, Thorium, Arsenic, Serotonin, or Vitamin D
that are suspected causative insults for EMF[5] as well as all other
known chemical species. The National Institute of Standard and
Technology(NIST) and SureChem Chemical searches(for details,
see URL link below) were finally employed to relate the former
formulae to chemical formulae and structure of all known
compounds in the respective databases.
D. Databases, Software and Algorithms
The Databases, Software and algorithms used in this study can
all freely be accessed by the reader at the following world-wide
web sites:
I. All NCBI BLAST Assembled Organismal genomes are
available at the NCBI URL:http://www.ncbi.nlm.nih.
gov/mapview/
II. SIB BLAST Tool is available at the following Expasy URL:
http://www.expasy.ch/cgi-bin/blast.pl)
III. The NCBI Viral BLAST against dsDNA viruses is
available at the NCBI URL:http://www.ncbi.nlm.nih.
gov/genomes/VIRUSES/Bitor.cgi?db=VOG&data=vog&
gdata=dsdna.defl
IV. The NCBI Viral Genotyping BLAST tool is available at
the NCBI URL:http://www.ncbi.nlm.nih.gov/projects/
genotyping/formpage.cgi
V. The Expasy Software Protparam used to determine
chemicalcompositionisavailableattheSwissProt/Uniprot
URL: http://www.expasy.ch/tools/protparam.html
VI. The SureChem software and algorithm is available at the
URL: http://www.freepatentsonline.com/
VII. The National Institute of Standards and Technology
(NIST) Chemical Formula Search Tool is available at the
NIST URL: http://webbook.nist.gov/chemistry/form-ser.
html
Supporting Information
Figure S1 Showing the Taxonomic Tree of all BLAST hits
obtained by querying the C-termini of TcP2b across a Swiss Prot
database using the BLAST tool at SIB. The Figure illustrates the
Taxonomic relationship, rooted on the query, of all hits obtained
by querying the 13 amino acid sequences of the C-termini of
TcP2b (EEEDDDMGFGLFD) across a Swiss Prot database using
the BLAST tool at SIB. The data was generated by the BLAST
tool at the following URL: SIB availablehttp://www.expasy.ch/
cgi-bin/blast.pl
Found at: doi:10.1371/journal.pone.0007420.s001 (0.03 MB
PDF)
File S1 Showing the only hits to the source of the two C-
terminal peptides of the ribosomal proteins TcP0: the 60S
acidic ribosomal protein P0 of T.cruzi using the BLAST-P tool
at NCBI( Default settings). This file illustrates the E-values and
score, description and details of the hits obtained by querying
the acidic termini of the T.cruzi ribosomal proteins TcP0
against a genome wide database of 31 protozoa proteins. Note
that despite the presence in the database of pathogens
previously suspected to be the causative insult of EMF such
as plasmodia [5], the only hits were those to the source of the
query peptide TcP0: the 60S acidic ribosomal protein P0 of
T.cruzi. The data was generated by the NCI BLAST-P
Software and algorithms [18,19]. Similar Data obtained with
the C-terminus of TcP2b is not shown. These results are
explained by the fact that in order to reduce errors in
alignment searches, the default settings do not permit database
searches that employ short-repetitive queries [18,19]. There-
fore, unless the filter is turned off, no results will be found.
Found at: doi:10.1371/journal.pone.0007420.s002 (0.07 MB
DOC)
File S2 Showing Scores and E values of hits obtained querying
C-termini of TcP2b across a Swiss Prot database using the BLAST
tool at SIB. Showing Scores and E values of hits obtained by
querying the 13 amino acid sequences of the C-termini of TcP2b
(EEEDDDMGFGLFD) across a Swiss Prot database using the
BLAST tool at SIB. The data was generated by the BLAST tool at
the following URL: SIB availablehttp://www.expasy.ch/cgi-bin/
blast.pl
Found at: doi:10.1371/journal.pone.0007420.s003 (0.87 MB
DOC)
File S3 Showing the Biophysical profiles of the acidic C-
terminus of the T.cruzi ribosomal P protein TcP0. The file
provides details of the biophysical profiles, including chemical
structure, amino acid composition, Theoretical PI, Instability
index, Extinction coefficient Aliphatic Index and Graavy of the C-
terminus peptide of TcP0 (EDDDDDFGMGALF). The data was
generated by the Expasy software Protparam [25]
Found at: doi:10.1371/journal.pone.0007420.s004 (0.24 MB
DOC)
File S4 Showing the Biophysical profiles of the acidic C-
terminus of the T.cruzi ribosomal P protein TcP2b. The file
provides details of the biophysical profiles, including chemical
structure, amino acid composition, Theoretical PI, Instability
index, Extinction coefficient Aliphatic Index and Graavy of the C-
terminus peptides of TcP2b (EEEDDDMGFGLFD). The data
was generated by the Expasy software Protparam [25]
Found at: doi:10.1371/journal.pone.0007420.s005 (0.24 MB
DOC)
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